Last Updated on eMC 27-03-2017 View medicine  | Teva Pharma B.V. Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Reasons for adding or updating:

  • Change to section 4 - how to report a side effect

Reasons for adding or updating:

  • Change to section 6 - marketing authorisation holder

Reasons for adding or updating:

  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC